Day: March 26, 2022

Montreal, Canada, March 25, 2022 (GLOBE NEWSWIRE) — (TSXV: GMN) GobiMin Inc. (the “Company” or “GobiMin”) announces that Mr. Hubert Marleau has tendered his resignation as Director of the Company effective on March 25, 2022. Concurrent with Mr. Hubert Marleau’s resignation, the Company is pleased to announce that Mr. Philippe Marleau has been appointed as Director of the Company with effect from March 25, 2022. Mr. Philippe Marleau is the son of Mr. Hubert Marleau. He is currently the chief executive officer of Palos Capital Corporation (“Palos”), a boutique financial services firm focused on wealth management and merchant banking activities. Previously, Philippe was the chief executive officer of IOU Financial Inc. (“IOU”), a tech-enabled lender to small businesses that is listed on the TSX Venture Exchange. He currently serves...

REDWOOD CITY, Calif., March 25, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on hematopoietic cell transplant therapies, today announced that, on March 21, 2022, it granted an option to purchase 1,704,328 shares of Jasper’s voting common stock (the “Option”) to Ronald Martell, Jasper’s newly appointed President and Chief Executive Officer. This inducement award was granted pursuant to the Jasper 2022 Inducement Equity Incentive Plan, approved by the compensation committee of Jasper’s board of directors on March 14, 2022, and granted as an inducement material to Mr. Martell’s employment with Jasper in accordance with Nasdaq Listing Rule 5635(c)(4). The Option has an exercise price of $3.54 per share and will vest over four years, with 25% of the total number of shares...